Daniel Gesua Sive Salvadori, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 38,658 shares at $54.90 ($2.1M) on 2017-12-14, disclosed to the SEC on 2017-12-14.
Open-market sale of $2.1M ABT by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.90 | 9,839 | $540K | 25.4% |
| 2 | $54.90 | 9,839 | $540K | 25.4% |
| 3 | $54.91 | 1,483 | $81K | 3.8% |
| 4 | $54.91 | 200 | $11K | 0.5% |
| 5 | $54.91 | 200 | $11K | 0.5% |
| 6 | $54.91 | 200 |
| $11K |
| 0.5% |
| 7 | $54.92 | 200 | $11K | 0.5% |
| 8 | $54.92 | 100 | $5K | 0.3% |
| 9 | $54.92 | 1,900 | $104K | 4.9% |
| 10 | $54.92 | 100 | $5K | 0.3% |
| 11 | $54.93 | 6,897 | $379K | 17.8% |
| 12 | $54.94 | 7,700 | $423K | 19.9% |
| Total | $54.91 avg | 38,658 | $2.1M | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $228K | — | Filing → |
| ABT | SELL | 2023-03-02 | $219K | — | Filing → |
| ABT | SELL | 2022-03-02 | $366K | — | Filing → |